Cargando…
A small molecule Nec-1 directly induces amyloid clearance in the brains of aged APP/PS1 mice
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the formation of toxic amyloid-β (Aβ) oligomers and plaques. Considering that Aβ misfolding and aggregation precedes the progressive development of cognitive impairment in AD, investigating a therapeutic means by c...
Autores principales: | Yang, Seung-Hoon, Shin, Jisu, Shin, Naewoo Neo, Hwang, Ji-Hyun, Hong, Sung-Chul, Park, Keunwan, Lee, Jae Wook, Lee, Sejin, Baek, Seungyeop, Kim, Kyeonghwan, Cho, Illhwan, Kim, YoungSoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414664/ https://www.ncbi.nlm.nih.gov/pubmed/30862818 http://dx.doi.org/10.1038/s41598-019-40205-5 |
Ejemplares similares
-
Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
por: Yang, Seung‐Hoon, et al.
Publicado: (2016) -
Correction: Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model
por: Kim, DaWon, et al.
Publicado: (2021) -
Four-week individual caging of male ICR mice alters body composition without change in body mass
por: Shin, Jisu, et al.
Publicado: (2018) -
Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model
por: Kim, DaWon, et al.
Publicado: (2020) -
Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models
por: Lee, Hee Yang, et al.
Publicado: (2022)